PortfoliosLab logo
Inari Medical, Inc. (NARI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45332Y1091

CUSIP

45332Y109

IPO Date

May 22, 2020

Highlights

Market Cap

$4.68B

EPS (TTM)

-$1.35

Total Revenue (TTM)

$299.21M

Gross Profit (TTM)

$255.82M

EBITDA (TTM)

-$23.82M

Year Range

$39.76 - $79.99

Target Price

$78.03

Short %

5.36%

Short Ratio

0.54

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period


NARI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of NARI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202556.06%0.38%56.65%
2024-12.28%-19.02%4.03%-22.18%33.90%-3.70%-3.30%-7.15%-4.60%17.36%7.27%-1.68%-21.36%
2023-10.24%-1.38%9.74%7.58%-9.06%-3.74%-1.84%16.73%-1.83%-7.17%-1.68%8.76%2.14%
2022-19.40%19.60%3.02%-10.97%-18.46%3.33%14.11%-10.61%4.74%5.91%-4.35%-13.62%-30.36%
20219.31%9.62%2.29%6.81%-23.92%7.28%-3.74%-8.83%-0.93%11.62%-8.82%10.58%4.56%
20203.51%10.09%16.06%42.19%-13.66%-4.09%4.34%26.38%105.34%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of NARI is 72, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of NARI is 7272
Overall Rank
The Sharpe Ratio Rank of NARI is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of NARI is 7373
Sortino Ratio Rank
The Omega Ratio Rank of NARI is 7474
Omega Ratio Rank
The Calmar Ratio Rank of NARI is 7272
Calmar Ratio Rank
The Martin Ratio Rank of NARI is 6969
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Inari Medical, Inc. (NARI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Inari Medical, Inc.. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Loading data...

Dividends

Dividend History


Inari Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Inari Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Inari Medical, Inc. was 70.53%, occurring on Apr 23, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-70.53%Mar 12, 2021784Apr 23, 2024
-27.5%Aug 31, 202042Oct 28, 202041Dec 28, 202083
-23.92%Feb 22, 202111Mar 8, 20213Mar 11, 202114
-15.57%Jan 26, 20212Jan 27, 20216Feb 4, 20218
-11.38%Jun 4, 202014Jun 23, 202012Jul 10, 202026

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Inari Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Inari Medical, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 30.8% positive surprise.


-0.40-0.30-0.20-0.100.000.10AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJuly
-0.09
-0.13
Actual
Estimate

Valuation

The Valuation section provides an overview of how Inari Medical, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for NARI relative to other companies in the Medical Devices industry. Currently, NARI has a P/S ratio of 8.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for NARI in comparison with other companies in the Medical Devices industry. Currently, NARI has a P/B value of 10.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items